Changes of matrix metalloproteinases in the stroma after corneal cross-linking in rabbits.

AIM To observe changes in the content of matrix metalloproteinases (MMPs) in the corneal stroma after corneal cross-linking (CXL) in rabbits, and further explore the corneal pathophysiological process after CXL. METHODS Forty-two rabbits (42 eyes) were randomly divided into seven groups. One group served as the control group, while the other six groups were treated with CXL. The concentrations of MMPs in corneal stroma were evaluated through parallel reaction monitoring at baseline and 3, 7, 15, 30, 90, and 180d after treatment. RESULTS The levels of MMP-2 in the corneal stroma of rabbits were 0.76±0.07, 2.78±1.39, 4.12±0.69, 2.00±0.29, 2.00±0.30, 1.22±0.18, and 1.35±0.18 (10-9 mol/g) at baseline and 3, 7, 15, 30, 90, and 180d after treatment, respectively. The contents of tissue inhibitor of metalloproteinase-1 (TIMP-1) were 1.83±0.26, 7.94±0.58, 6.95±2.64, 3.81±0.48, 3.07±0.92, 1.72±0.19, and 1.69±0.74 (10-9 mol/g), respectively. The ratios of MMP-2/TIMP-1 were 0.42±0.33, 0.36±0.20, 0.62±0.10, 0.54±0.15, 0.68±0.13, 0.71±0.10, and 0.68±0.09, respectively. After CXL, the expression of MMP-2 and TIMP-1 in the rabbit corneal stroma was initially increased and subsequently decreased. The levels of MMP-2 remained higher than those recorded at baseline 180d after treatment, but it was not statistically significant. The levels of TIMP-1 returned to baseline levels at 90d after treatment. The ratio of MMP-2/TIMP-1 started to rise from 7d after CXL. It was significantly higher than that calculated at baseline 30-180d after CXL. The results for MMP-1, -3, -7, -9, -13, and TIMP-2 were negative. CONCLUSION CXL can lead to changes in the content of MMP-2 and TIMP-1 in the rabbit corneal stroma. The ratio of MMP-2/TIMP-1 remains higher versus baseline, indicating that MMP-2 is involved in the corneal pathophysiological process after CXL.

[1]  Mansour M Al-Mohaimeed.  Combined corneal CXL and photorefractive keratectomy for treatment of keratoconus: a review. , 2019, International journal of ophthalmology.

[2]  C. Inglehearn,et al.  Matrix metalloproteinases in keratoconus – Too much of a good thing? , 2019, Experimental eye research.

[3]  S. Jacob,et al.  Keratoconus Progression in Patients With Allergy and Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test , 2017, Eye & contact lens.

[4]  A. Kalkancı,et al.  Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage , 2018, Mycopathologia.

[5]  H. Hashemi,et al.  Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes , 2017, Journal of current ophthalmology.

[6]  K. Meek,et al.  An investigation into corneal enzymatic resistance following epithelium-off and epithelium-on corneal cross-linking protocols , 2016, Experimental eye research.

[7]  J. Mohamed‐Hamsho,et al.  Corneal Melting after Collagen Cross-Linking for Keratoconus in a Thin Cornea of a Diabetic Patient Treated with Topical Nepafenac: A Case Report with a Literature Review , 2016, Case Reports in Ophthalmology.

[8]  Rodolfo Mastropasqua,et al.  Structural modifications and tissue response after standard epi-off and iontophoretic corneal crosslinking with different irradiation procedures. , 2014, Investigative ophthalmology & visual science.

[9]  J. Błasiak,et al.  Role of biochemical factors in the pathogenesis of keratoconus. , 2014, Acta biochimica Polonica.

[10]  Xiujun Peng,et al.  Corneal Collagen Fibril Changes After Ultraviolet A/Riboflavin Corneal Crosslinking , 2014, Cornea.

[11]  G. Petrovski,et al.  Alterations of Tear Mediators in Patients with Keratoconus after Corneal Crosslinking Associate with Corneal Changes , 2013, PloS one.

[12]  M. Willcox,et al.  Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus , 2013, Clinical & experimental optometry.

[13]  G. Conrad,et al.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases. , 2013, Investigative ophthalmology & visual science.

[14]  D. Pye,et al.  Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus , 2012, Acta ophthalmologica.

[15]  M. Washington,et al.  Precision of Multiple Reaction Monitoring Mass Spectrometry Analysis of Formalin-Fixed, Paraffin-Embedded Tissue , 2012, Journal of proteome research.

[16]  Hermann Herbst,et al.  Wound Healing in the Rabbit Cornea After Corneal Collagen Cross-Linking With Riboflavin and UVA , 2007, Cornea.

[17]  F. J. Matthews,et al.  Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. , 2006, Biochimica et biophysica acta.

[18]  V. Vasiliou,et al.  Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. , 2005, Investigative ophthalmology & visual science.

[19]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[20]  G. A. Limb,et al.  Matrix metalloproteinases in disease and repair processes in the anterior segment. , 2002, Survey of ophthalmology.

[21]  M. Kenney,et al.  Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. , 1998, Current eye research.